Lawrence J. Marnett

43.7k total citations · 7 hit papers
518 papers, 35.2k citations indexed

About

Lawrence J. Marnett is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Lawrence J. Marnett has authored 518 papers receiving a total of 35.2k indexed citations (citations by other indexed papers that have themselves been cited), including 218 papers in Pharmacology, 215 papers in Molecular Biology and 113 papers in Organic Chemistry. Recurrent topics in Lawrence J. Marnett's work include Inflammatory mediators and NSAID effects (167 papers), Eicosanoids and Hypertension Pharmacology (83 papers) and DNA Repair Mechanisms (63 papers). Lawrence J. Marnett is often cited by papers focused on Inflammatory mediators and NSAID effects (167 papers), Eicosanoids and Hypertension Pharmacology (83 papers) and DNA Repair Mechanisms (63 papers). Lawrence J. Marnett collaborates with scholars based in United States, United Kingdom and Netherlands. Lawrence J. Marnett's co-authors include Carol A. Rouzer, Brenda C. Crews, Amit S. Kalgutkar, Kevin R. Kozak, Scott W. Rowlinson, James D. West, Philip J. Kingsley, Jason D. Morrow, Anna L. Blobaum and James N. Riggins and has published in prestigious journals such as Nature, Science and Chemical Reviews.

In The Last Decade

Lawrence J. Marnett

514 papers receiving 34.2k citations

Hit Papers

Oxyradicals and DNA damage 1985 2026 1998 2012 2000 2005 1999 2001 1992 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Oxyradicals and DNA damage
    2000 1.5k citations Lawrence J. Marnett profile →
  2. Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
    2005 1.2k citations Philip J. Kingsley, Ken Mackie et al. profile →
  3. Lipid peroxidation—DNA damage by malondialdehyde
    1999 1.0k citations Lawrence J. Marnett profile →
  4. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.
    2001 702 citations Lawrence J. Marnett et al. PubMed profile →
  5. Aspirin and the potential role of prostaglandins in colon cancer.
    1992 598 citations Lawrence J. Marnett PubMed profile →
  6. Cyclooxygenases: structural and functional insights
    2008 515 citations Carol A. Rouzer, Lawrence J. Marnett Journal of Lipid Research profile →
  7. Naturally occurring carbonyl compounds are mutagens Salmonella tester strain TA104
    1985 443 citations Lawrence J. Marnett et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Lawrence J. Marnett 13.3k 12.1k 5.8k 4.2k 4.1k 518 35.2k
Jason D. Morrow 12.7k 1.0× 7.9k 0.7× 4.7k 0.8× 2.3k 0.6× 6.5k 1.6× 404 42.4k
Bengt Samuelsson 12.8k 1.0× 14.9k 1.2× 4.4k 0.8× 1.8k 0.4× 9.5k 2.3× 426 42.8k
Salvatore Cuzzocrea 14.0k 1.0× 5.2k 0.4× 1.9k 0.3× 1.9k 0.5× 2.4k 0.6× 923 43.4k
Edward A. Dennis 23.0k 1.7× 3.3k 0.3× 2.3k 0.4× 2.0k 0.5× 5.3k 1.3× 390 36.7k
George L. Ellman 15.4k 1.2× 12.7k 1.0× 5.2k 0.9× 1.2k 0.3× 3.0k 0.7× 31 48.9k
David L. DeWitt 4.8k 0.4× 9.1k 0.8× 1.5k 0.3× 1.6k 0.4× 2.9k 0.7× 109 17.4k
Joseph L. Witztum 18.4k 1.4× 2.9k 0.2× 3.1k 0.5× 7.3k 1.8× 3.3k 0.8× 460 72.1k
Mats Hámberg 9.2k 0.7× 8.8k 0.7× 2.7k 0.5× 793 0.2× 6.8k 1.7× 336 27.1k
John R. Vane 13.2k 1.0× 24.7k 2.0× 3.8k 0.7× 2.3k 0.5× 11.9k 2.9× 468 63.3k
Bruce D. Hammock 18.9k 1.4× 4.4k 0.4× 5.1k 0.9× 2.7k 0.6× 24.0k 5.9× 1.4k 57.6k

Countries citing papers authored by Lawrence J. Marnett

Since Specialization
Citations

This map shows the geographic impact of Lawrence J. Marnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence J. Marnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence J. Marnett more than expected).

Fields of papers citing papers by Lawrence J. Marnett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence J. Marnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence J. Marnett. The network helps show where Lawrence J. Marnett may publish in the future.

Co-authorship network of co-authors of Lawrence J. Marnett

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence J. Marnett. A scholar is included among the top collaborators of Lawrence J. Marnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence J. Marnett. Lawrence J. Marnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lo, Justin H., Mukesh Kumar Gupta, Thomas A. Werfel, et al.. (2025). Polymeric Nanoparticles Enable Targeted Visualization of Drug Delivery in Breast Cancer. Molecular Pharmaceutics. 22(5). 2392–2401.
2.
Aleem, Ansari M., Michelle M. Mitchener, Philip J. Kingsley, Carol A. Rouzer, & Lawrence J. Marnett. (2024). Temporal dissociation of COX-2-dependent arachidonic acid and 2-arachidonoylglycerol metabolism in RAW264.7 macrophages. Journal of Lipid Research. 65(9). 100615–100615. 4 indexed citations
3.
Nikas, Spyros P., Yingpeng Liu, Alex Straiker, et al.. (2024). Chiral Me-2-arachidonoyl Glycerols: The First Potent Endocannabinoid Glyceride Templates with Stability to COX-2. ACS Medicinal Chemistry Letters. 15(6). 965–971. 4 indexed citations
4.
Kondev, Veronika, Amanda Morgan, Nathan D. Winters, et al.. (2022). The Endocannabinoid 2-Arachidonoylglycerol Bidirectionally Modulates Acute and Protracted Effects of Predator Odor Exposure. Biological Psychiatry. 92(9). 739–749. 10 indexed citations
5.
Morgan, Amanda, Philip J. Kingsley, Michelle M. Mitchener, et al.. (2018). Detection of Cyclooxygenase-2-Derived Oxygenation Products of the Endogenous Cannabinoid 2-Arachidonoylglycerol in Mouse Brain. ACS Chemical Neuroscience. 9(7). 1552–1559. 29 indexed citations
6.
Bedse, Gaurav, Rebecca J. Bluett, Andrew D. Gaulden, et al.. (2018). Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors. Translational Psychiatry. 8(1). 92–92. 86 indexed citations
7.
Pulley, Jill M., Jana K. Shirey-Rice, Robert R. Lavieri, et al.. (2017). Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics. Assay and Drug Development Technologies. 15(3). 113–119. 30 indexed citations
8.
Boutaud, Olivier, Taneem Amin, Hyun Seok Hwang, et al.. (2016). Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma Metastasis. Cancer Prevention Research. 9(11). 855–865. 44 indexed citations
9.
Gamble‐George, Joyonna, Rita Báldi, Lindsay R. Halladay, et al.. (2016). Cyclooxygenase-2 inhibition reduces stress-induced affective pathology. eLife. 5. 45 indexed citations
10.
Cekanova, Maria, Md. Jashim Uddin, Joseph W. Bartges, et al.. (2013). Molecular Imaging of Cyclooxygenase-2 in Canine Transitional Cell Carcinomas In Vitro and In Vivo. Cancer Prevention Research. 6(5). 466–476. 39 indexed citations
11.
Liu, Qi, Jody C. Ullery, Jing Zhu, et al.. (2013). RNA-seq data analysis at the gene and CDS levels provides a comprehensive view of transcriptome responses induced by 4-hydroxynonenal. Molecular BioSystems. 9(12). 3036–3046. 9 indexed citations
12.
Gregori‐Puigjané, Elisabet, Vincent Setola, Jérôme Hert, et al.. (2012). Identifying mechanism-of-action targets for drugs and probes. Proceedings of the National Academy of Sciences. 109(28). 11178–11183. 134 indexed citations
13.
Rouzer, Carol A. & Lawrence J. Marnett. (2011). Green Tea Gets Molecular. Cancer Prevention Research. 4(9). 1343–1345. 2 indexed citations
14.
Uddin, Md. Jashim, Brenda C. Crews, Kebreab Ghebreselasie, et al.. (2011). Fluorinated COX-2 Inhibitors as Agents in PET Imaging of Inflammation and Cancer. Cancer Prevention Research. 4(10). 1536–1545. 62 indexed citations
15.
Zhang, Bing, Zhiao Shi, Dexter T. Duncan, et al.. (2011). Relating protein adduction to gene expression changes: a systems approach. Molecular BioSystems. 7(7). 2118–2127. 24 indexed citations
16.
Uddin, Md. Jashim, Brenda C. Crews, Anna L. Blobaum, et al.. (2010). Selective Visualization of Cyclooxygenase-2 in Inflammation and Cancer by Targeted Fluorescent Imaging Agents. Cancer Research. 70(9). 3618–3627. 151 indexed citations
17.
Sun, Xiaofei, Haibin Wang, Masaru Okabe, et al.. (2008). Genetic Loss of Faah Compromises Male Fertility in Mice1. Biology of Reproduction. 80(2). 235–242. 45 indexed citations
18.
Rouzer, Carol A., et al.. (2005). RAW264.7 cells lack prostaglandin-dependent autoregulation of tumor necrosis factor-α secretion. Journal of Lipid Research. 46(5). 1027–1037. 34 indexed citations
19.
Nirodi, Chaitanya S., Brenda C. Crews, Kevin R. Kozak, Jason D. Morrow, & Lawrence J. Marnett. (2004). The glyceryl ester of prostaglandin E 2 mobilizes calcium and activates signal transduction in RAW264.7 cells. Proceedings of the National Academy of Sciences. 101(7). 1840–1845. 97 indexed citations
20.
Block, Gladys, Jeffrey B. Blumberg, A. T. Diplock, et al.. (1994). Summary of the round table discussion on strategies for cancer prevention: diet, food, additives, supplements, and drugs.. PubMed. 54(7 Suppl). 2044s–2051s. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason D. Morrow Breakdown of academic impact, for papers by Bengt Samuelsson Breakdown of academic impact, for papers by Salvatore Cuzzocrea Breakdown of academic impact, for papers by Edward A. Dennis Breakdown of academic impact, for papers by George L. Ellman Breakdown of academic impact, for papers by David L. DeWitt Breakdown of academic impact, for papers by Joseph L. Witztum Breakdown of academic impact, for papers by Mats Hámberg Breakdown of academic impact, for papers by John R. Vane Breakdown of academic impact, for papers by Bruce D. Hammock
Rankless by CCL
2026